Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis.
Cheng HT, Huang HC, Lee TY, Liao YH, Sheng YH, Jin PR, Huang KW, Chen LH, Chen YT, Liu ZY, Lin TC, Wang HC, Chao CH, Juang IP, Su CT, Huang KH, Lin SL, Wang J, Sung YC, Chen Y.
Cheng HT, et al. Among authors: liao yh.
J Control Release. 2022 Jun;346:169-179. doi: 10.1016/j.jconrel.2022.04.004. Epub 2022 Apr 23.
J Control Release. 2022.
PMID: 35429575